MedPath

Dhindsa Group Of Companies, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

14

Active:0
Completed:6

Trial Phases

2 Phases

Phase 2:5
Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 2
5 (50.0%)
Not Applicable
4 (40.0%)
phase_2_3
1 (10.0%)
No trials found

News

India Launches First Indigenous HPV Test Kits for Cervical Cancer Screening

• Indigenously developed HPV test kits for cervical cancer screening were launched in Delhi, targeting the seven to eight most common cancer-causing HPV types specific to India's population. • The RTPCR-based diagnostic kits, validated through collaborative research led by AIIMS Delhi, offer a cost-effective alternative to traditional Pap smears and HPV DNA tests for national cancer screening programs. • With cervical cancer being the second most common cancer among Indian women and accounting for 25% of global mortality, these kits align with WHO's recommendation for HPV testing as the preferred screening method.

Breakthrough Gene Therapy for Maple Syrup Urine Disease Shows Promise in Animal Models

UMass Chan researchers have developed a gene therapy that successfully prevented death and normalized growth in animals with maple syrup urine disease, offering hope for patients with limited treatment options.

Izotropic Advances Breast Cancer Screening with FDA Pre-Submission for IzoView Breast CT System

Izotropic Corp. has filed a pre-submission with the FDA for its IzoView Breast CT Imaging System for breast cancer screening.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.